• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 3
  3. Author

Online ISSN: 2515-8260

Volume9, Issue3

Indirubin-3'-Oxime Eliminates Human Cholangiocarcinoma Through Apoptosis and Cell Cycle-Arrest

    Parul Singh

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 3, Pages 642-649

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: Cholangiocarcinoma (CCA) is one of the most prevalent diseases in the
South Asia. Failing to determine this disease on time tends to be a great challenge in its
diagnosis. In several human malignancies, indirubin-3'-oxime (I3O) has been found to
decrease cell growth, cause cessation of cell cycle, and cell death.
Objective: The anticancer effects of I3O on human CCA cells will be demonstrated by
exhibiting induced cessation of cell cycle and apoptosis in I3O-treated cells.
Methods: The viability, apoptosis of cells and cessation of cell cycle were all measured.
Analysis using Western blotting, flow cytometry and immunofluorescence.
Results: According to the findings, in CCA cells, I3O treatment inhibits cell growth and
induces cessation of cell cycle as well as caspase-dependent death.
Conclusion: These data imply that I3O, by regulating the cell cycle and generating
apoptosis, could inhibit tumour growth and hence be a viable treatment drug for
human CCA.
Keywords:
  • PDF (380 K)
  • XML
(2022). Indirubin-3'-Oxime Eliminates Human Cholangiocarcinoma Through Apoptosis and Cell Cycle-Arrest. European Journal of Molecular & Clinical Medicine, 9(3), 642-649.
Parul Singh. "Indirubin-3'-Oxime Eliminates Human Cholangiocarcinoma Through Apoptosis and Cell Cycle-Arrest". European Journal of Molecular & Clinical Medicine, 9, 3, 2022, 642-649.
(2022). 'Indirubin-3'-Oxime Eliminates Human Cholangiocarcinoma Through Apoptosis and Cell Cycle-Arrest', European Journal of Molecular & Clinical Medicine, 9(3), pp. 642-649.
Indirubin-3'-Oxime Eliminates Human Cholangiocarcinoma Through Apoptosis and Cell Cycle-Arrest. European Journal of Molecular & Clinical Medicine, 2022; 9(3): 642-649.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 92
  • PDF Download: 125
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus